力生制药：公司子公司中央药业持有的是天士力生物医药产业集团有限公司12.15%股权

Group 1 - The core point of the article is that Lisheng Pharmaceutical (002393) announced through an interactive platform that its subsidiary, Central Pharmaceutical, holds a 12.15% stake in Tian Shi Li (600535) Biopharmaceutical Industry Group Co., Ltd [1]